MD - Mednax Non-GAAP EPS of $0.52 beats by $0.09 revenue of $499M beats by $16.5M
Mednax press release (NYSE:MD): Q4 Non-GAAP EPS of $0.52 beats by $0.09. Revenue of $499M (+19.7% Y/Y) beats by $16.5M. On a preliminary basis, Mednax anticipates that its 2022 Adjusted EBITDA, as defined above, will be at least $270 million.
For further details see:
Mednax Non-GAAP EPS of $0.52 beats by $0.09, revenue of $499M beats by $16.5M